Abstract / Description of output
Triple-negative breast cancer (TNBC) is characterized by high rates of metastasis and no available molecular targets. CTCs derived xenografts (CDX) have demonstrated to be a promising tool for understanding cancer biology. In this study a CDX from a TNBC patient was developed for the first time. After CDX characterization, WNT signalling was found as the main mechanism related with this tumor biology and potential CTCs markers were identified and subsequently validated in TNBC patients. In this cohort high levels of MELK expression were associated with poorer survival rates. Overall, this study demonstrates that CTCs from TNBC are tumorigenic and CDXs are a useful model to obtain valuable information about the tumor. This article is protected by copyright. All rights reserved.
Keywords / Materials (for Non-textual outputs)
- triple-negative breast cancer
- Circulating Tumor Cells (CTCs)
- CTCs-Derived xenograft (CDX)